SCHEMBL7788476

SCHEMBL7788476

Brc1cc(Br)c(O[PH2](Oc2c(Br)cc(Br)cc2Br)Oc2c(Br)cc(Br)cc2Br)c(Br)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.38
▸ ALOX15 P16050 4/20 0.36
▸ ALOX12 P18054 3/20 0.36
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35
▸ GABRA2 P47869 1/20 0.35
▸ GABRB2 P47870 1/20 0.35
▸ AKR1B1 P15121 1/20 0.33
▸ HSP90AA1 P07900 1/20 0.33
▸ TLR9 Q9NR96 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ CA2 P00918 1/20 0.32
▸ CA4 P22748 1/20 0.32
▸ AHR P35869 1/20 0.32
▸ MEN1 O00255 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7738112 0.79 TDP1 (0.36) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL3803700 0.73 TDP1 (0.45) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL27503034 0.71 TSHR (0.43) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL28973883 0.69 TDP1 (0.41) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL301662 0.69 HSD17B10 (0.59) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL11451272 0.67 TSHR (0.39) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL457449 0.67 TDP1 (0.39) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL94118 0.67 KLK1 (0.45) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL8129030 0.67 TDP1 (0.39) TDP1CYP3A4TSHRHSD17B10ALOX15
SCHEMBL4644330 0.65 HSD17B10 (0.46) TDP1CYP3A4TSHRHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0906327-B1 INTERMEDIATES FOR OLIGONUCLEOTIDE SYNTHESIS ISIS PHARMACEUTICALS INC (US) 2001-12-12 — — EP disclosed
US-6329519-B1 NUCLEOTIDE OF DEFINED STRUCTURE ISIS PHARMACEUTICALS, INC. 2001-12-11 — — US disclosed
EP-0906327-A2 INTERMEDIATES FOR OLIGONUCLEOTIDE SYNTHESIS Novartis AG (CH) 1999-04-07 — — EP disclosed
WO-1997047636-A2 INTERMEDIATES FOR OLIGONUCLEOTIDE SYNTHESIS NOVARTIS AG (CH) 1997-12-18 — — WO disclosed
Send feedback